Takeda Pharmaceutical Company Limited
Anti-MIF immunohistochemistry
Last updated:
Abstract:
The present invention pertains to the specific detection of MIF, in particular oxMIF, in tissues. A detection method is provided which uses immunohistochemistry and wherein specific anti-oxMIF antibodies are used.
Status:
Grant
Type:
Utility
Filling date:
9 Jul 2013
Issue date:
2 Aug 2022